Cegedim

Equities

CGM

FR0000053506

Software

Market Closed - Euronext Paris 11:35:14 2024-04-26 am EDT 5-day change 1st Jan Change
13.75 EUR +1.85% Intraday chart for Cegedim -0.72% -23.01%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cegedim: 7% sales growth in Q1 CF
Transcript : Cegedim SA, Q1 2024 Sales/ Trading Statement Call, Apr 25, 2024
Cegedim: 23% increase in ROC in 2023 CF
Transcript : Cegedim SA, 2023 Earnings Call, Mar 27, 2024
Cegedim SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cegedim: acquisition in the dental care sector CF
Cegedim Buys French Dental Software Company Visiodent MT
Cegedim: certification obtained for data centers CF
Cegedim: 8% sales growth in Q4 CF
Cegedim: investment in start-up Phealing CF
Cegedim SA acquired unknown majority stake in Phealing. CI
Cegedim: THIN database extended to Germany CF
Cegedim: a scientific committee created for THIN CF
Cegedim: growth confirmed, targets maintained CF
Cegedim Provides Revenue Guidance for the Full Year 2023 CI
Cegedim: successful partnership with Shift Technology CF
Cegedim launches partnership with adeRHis CF
Cegedim: net loss widens in 1st half CF
Cegedim SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Cegedim SA Provides Revenue Guidance for the Full Year 2023 CI
Cegedim: new partnership with Gustave Roussy CF
Cegedim: final ACPR approval for CETIP CF
Cegedim: confident for fiscal 2023, share price rises CF
Cegedim: merger of two subsidiaries CF
Global markets live: Shell, Netflix, Nike, Ocado, Tesla... Our Logo
Chart Cegedim
More charts
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (1.1%). France accounts for 89.7% of net sales.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
13.75 EUR
Average target price
19.37 EUR
Spread / Average Target
+40.85%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CGM Stock
  4. News Cegedim
  5. Cegedim Acquires Traceability Software Specialist Sedia